Kodiak Sciences Inc. (KOD) Financials
KOD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 256.8 million | 195.7 million |
| March 31, 2026 | 306.0 million | 193.9 million |
| Dec. 31, 2025 | 351.5 million | 194.2 million |
| Sept. 30, 2025 | 218.1 million | 194.4 million |
KOD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -46.6 million | 11.6 million |
| March 31, 2026 | -41.0 million | 12.2 million |
| Dec. 31, 2025 | -39.4 million | 27.3 million |
| Sept. 30, 2025 | -32.9 million | 14.0 million |
KOD Net Income
No data available :(
KOD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 125.9 million | 42.9 million | 42.9 million |
| March 31, 2026 | 169.5 million | 100.0 million | 44.3 million |
| Dec. 31, 2025 | 209.9 million | 100.0 million | 47.1 million |
| Sept. 30, 2025 | 72.0 million | - | 62.2 million |
KOD Shares Outstanding
KOD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 352000 | 56.1 million | 10.8 million | - |
| March 31, 2026 | 942000 | 48.5 million | 11.2 million | - |
| Dec. 31, 2025 | 43000 | 45.5 million | 12.0 million | - |
| Sept. 30, 2025 | 59999 | 50.5 million | 11.9 million | - |
KOD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 6.3 million |
| Dec. 31, 2025 | - | -19.8 million |
| Sept. 30, 2025 | - | 6.5 million |
KOD
Price: $81.02
52 week price:
Earnings Per Share: -4.19 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 76500
Market Capitalization: 5.9 billion